PheneX buys Lion bioscience discovery assets

Nuclear receptor specialist PheneX (Heidelberg, Germany) acquired from Lion bioscience (FSE:LIO; LEON) the assets that made up LIO's iD3 nuclear receptor drug discovery unit. LIO discontinued its iD3 ...